Innovations in Actinic Keratosis

Rawlings E Lyle1, Linh H Tran1, Daniel B Eisen2

  • 1Department of Dermatology, University of California, Davis School of Medicine, 4610 X Street, Sacramento, CA 95817, USA.

Dermatologic Clinics
|November 14, 2024
PubMed

Insights

Recent advancements in actinic keratosis (AK) management include new therapies and understanding of disease progression. Personalized, technology-enhanced approaches aim to improve patient outcomes and prevent skin cancer.

Area of Science:

  • Dermatology and Oncology
  • Molecular Biology
  • Microbiology

Background:

  • Actinic keratosis (AK) is a common precursor to squamous cell carcinoma.
  • Effective management and early detection are crucial for preventing cancer progression.

Purpose of the Study:

  • To review recent therapeutic breakthroughs and pathophysiological discoveries in AK management.
  • To explore advances in photodynamic therapy and new topical treatments.
  • To detail genomic and transcriptomic pathways from AK to squamous cell carcinoma, including microbiome roles.

Main Methods:

  • Literature review of recent studies on AK management.
  • Analysis of therapeutic innovations and diagnostic improvements.
  • Examination of molecular pathways and microbiome influence.

Main Results:

  • Highlighting novel treatments and improved diagnostic strategies.
  • Elucidating the genomic and transcriptomic landscape of AK progression.
  • Emphasizing the role of the cutaneous microbiome in AK development.

Conclusions:

  • Current insights support personalized, technology-enhanced AK treatment strategies.
  • Improved patient care and adherence are key to better outcomes.
  • Preventing AK progression to squamous cell carcinoma remains a primary goal.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.8K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K